Skip to Content

Tolterodine Tartrate Extended Release Capsules

Last Updated: July 10, 2015
Status: Resolved

Products Affected - Description

There are no products affected.

Reason for the Shortage

  • Mylan discontinued tolterodine extended release 2 mg and 4 mg capsules in 90 count bottles in April 2014.
  • Teva could not provide a reason for the shortage.

Available Products

Tolterodine tartrate extended release capsules, Mylan Institutional
2 mg capsules, 30 count unit-dose (NDC 51079-0197-03)
4 mg capsules, 30 count unit-dose (NDC 51079-0198-03)

Tolterodine tartrate extended release capsules, Mylan
2 mg capsules, 30 count (NDC 00378-3402-93)
2 mg capsules, 500 count (NDC 00378-3402-05)
4 mg capsules, 30 count (NDC 00378-3404-93)


Tolterodine tartrate extended release capsules, Teva
2 mg capsules, 30 count (NDC 00093-2050-56)
2 mg capsules, 90 count (NDC 00093-2050-98)
2 mg capsules, 500 count (NDC 00093-2050-05)
4 mg capsules, 30 count (NDC 00093-2049-56)
4 mg capsules, 90 count (NDC 00093-2049-98)
4 mg capsules, 500 count (NDC 00093-2049-05)
 
Detrol LA, Pfizer
2 mg capsules, 30 count (NDC 00009-5190-01)
2 mg capsules, 90 count (NDC 00009-5190-02)
2 mg capsules, 500 count (NDC 00009-5190-03)
2 mg capsules, 100 count unit-dose (NDC 00009-5190-04)
4 mg capsules, 30 count (NDC 00009-5191-01)
4 mg capsules, 90 count (NDC 00009-5191-02)
4 mg capsules, 500 count (NDC 00009-5191-03)
4 mg capsules, 100 count unit-dose (NDC 00009-5191-04)

Estimated Resupply Dates

All presentations are available.

Updated

July 10, May 18, March 23, January 29, 2015; November 12, September 16, August 1, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide